Important: VAERS reports alone cannot determine if a vaccine caused an adverse event. Reports may contain incomplete, inaccurate, or unverified information. Correlation does not equal causation.
#1788 most reported symptom for this vaccine
Hypertransaminasaemia has been reported 134 times in association with COVID-19 Vaccine vaccination in VAERS. This represents 0.0% of all 1,121,388 reports for this vaccine.
Among these reports, 26 mentioned death (19.40%) and 118 involved hospitalization (88.1%).
Hypertransaminasaemia is the #1788 most frequently reported symptom for COVID-19 Vaccine out of 9223 total symptoms.
Disclaimer: VAERS reports describe events that occurred after vaccination but do not establish that the vaccine caused the event. Many reported symptoms may be coincidental or related to underlying conditions.
Seeing 134 reports of Hypertransaminasaemia after COVID-19 Vaccine vaccination may seem alarming, but context is critical. With 1,121,388 total reports for this vaccine (representing many millions of doses), Hypertransaminasaemia appears in only 0.0% of reports.
The 19.40% mortality rate among these reports is elevated, but this reflects the severity of the condition itself rather than vaccine causation.
This data comes from the Vaccine Adverse Event Reporting System (VAERS), jointly managed by CDC and FDA.